Glass House Brands Inc.
Glass House Brands Inc. (GLASF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
glasf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 5 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Glass House Brands Inc.You GLASF | $1.0B | N/A | — | -$0.42 |
 Allergy Therapeutics plc AGYTF | $655M | N/A | — | -$0.01 |
 Boiron S.A. BOIRF | $554M | 42.15x | +88.2% | $0.65 |
 Cresco Labs Inc. CRLBF | $332M | N/A | — | -$0.42 |
 Elite Pharmaceuticals, Inc. ELTP | $401M | N/A | — | -$0.00 |
 Hua Medicine (Shanghai) Ltd. HUMDF | $431M | 2.63x | -88.2% | $1.09 |
Industry Average 2 peers with valid PE | — | 22.39x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Glass House Brands Inc. (GLASF) measures how much investors pay for each dollar of the company's trailing earnings. GLASF's current PE ratio of N/A is calculated by dividing its stock price of $13.20 by its TTM earnings per share of -$0.42.
Frequently asked questions
GLASF pe ratio · 6 questionsGLASF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $13.20 and TTM EPS of -$0.42. Data sourced from Financial Modeling Prep via GLASF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Glass House Brands Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09